- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05730894
Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation. (ECMO)
Predictors of Mortality in Patients With VA-Extracorporeal Membrane Oxygenation. A Retrospective Data Review.
Study Overview
Detailed Description
Extracorporeal membrane oxygenation (ECMO) is an advanced life support modality for critically ill patients with refractory cardiac or respiratory failure. It is a temporary support for cardiorespiratory failure, bridging time for recovery or permanent assist. Besides, ECMO could be used in a variety of clinical presentations, such as severe traumas, extracorporeal-assisted rewarming (ECAR) of accidental deep hypothermia, and can be used as a bridge to lung or heart transplant.
Cardiogenic shock can be a fatal condition with poor prognosis. Conventional treatments for cardiogenic shock include vasopressor agents guided by invasive monitoring, and intraaortic balloon pump support. There has been growing interest in the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) as a salvage therapy for patients in cardiogenic shock refractory to conventional treatments. However, there is a low rate of survival to weaning or bridging therapy among patients with cardiogenic shock requiring ECMO (42-56%). Moreover, VA-ECMO use is associated with complications, including bleeding, renal failure. Thus, the benefits of this potentially life-saving support is still subject to discussion, especially for VA-ECMO use in the setting of cardiogenic shock as the evidence is scarce. Therefore, it important to identify the patients' related factors that may be associated with poor outcomes using real-world data. We will conduct a retrospective observational study of all patients at Heart Hospital who required VA-ECMO support due to cardiogenic shock during 1/06/2016 and 1/06/2022 with the aim of quantifying the incidence of in-hospital mortality among patients who required VA-ECMO in the setting of cardiogenic shock along with determining the predictors of mortality.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Alaa Rahhal, Msc
- Phone Number: 44395646
- Email: ARahhal1@hamad.qa
Study Locations
-
-
DA
-
Doha, DA, Qatar, 3050
- Recruiting
- Hamad Medical Corporation
-
Contact:
- Alaa Rahhal, MSc Pharma
- Email: ARahhal1@hamad.qa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults with the age of ≥ 18 years
- Requiring VA-ECMO or VAV-ECMO support
Exclusion Criteria:
- Requiring VV-ECMO support
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mortality
Time Frame: 6 months
|
mortality in patients who had VA-ECMO
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
bacterial pathogens responsible for infection-related mortality in VA-ECMO
Time Frame: 1 month
|
infection
|
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morality
-
National Yang Ming Chiao Tung University HospitalCompletedMorality
-
University of Cape TownBill and Melinda Gates FoundationCompleted
-
NYU Langone HealthCompleted
-
Baqiyatallah Medical Sciences UniversityNot yet recruitingMorality | Treatment Compliance
-
West China HospitalCompletedBody Composition | Cancer Survivor | Morality
-
National Defense Medical Center, TaiwanCompletedCardiovascular Diseases | Morality | Intensity CareTaiwan
-
Karolinska InstitutetRecruitingCardiovascular Diseases | Bariatric Surgery Candidate | MoralitySweden
-
University of California, San FranciscoBill and Melinda Gates Foundation; Ministry of Health, NigerRecruitingChild Health | Morality | Implementation | Resistance BacterialUnited States
-
ABDULZAHRA HUSSAINKing's College Hospital NHS Trust; Spire, Inc.; Heart of England NHS Trust; The... and other collaboratorsCompletedMorality | Revisions After MGB/OAGB | Morbidities